Tom Frohlich
Private Equity Investor presso Versant Ventures Canada Ltd.
Profilo
Tom Frohlich is currently an Entrepreneur-in-Residence at Versant Ventures Canada Ltd.
He previously held positions as Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Chief Business Officer at Chinook Therapeutics, Inc. from 2019 to 2021.
Mr. Frohlich has an MBA from the University of Oxford and an undergraduate degree from the University of Victoria.
Posizioni attive di Tom Frohlich
Società | Posizione | Inizio |
---|---|---|
Versant Ventures Canada Ltd. | Private Equity Investor | - |
Precedenti posizioni note di Tom Frohlich
Società | Posizione | Fine |
---|---|---|
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2018 |
ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 01/03/2018 |
CHINOOK THERAPEUTICS, INC. | Chief Operating Officer | - |
Formazione di Tom Frohlich
University of Oxford | Masters Business Admin |
University of Victoria | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Aziende private | 3 |
---|---|
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Health Technology |
Versant Ventures Canada Ltd. | Finance |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Tom Frohlich